InMode Ltd. Stock

Equities

INMD

IL0011595993

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:04 2024-05-31 pm EDT 5-day change 1st Jan Change
19.12 USD +1.32% Intraday chart for InMode Ltd. +3.46% -14.03%
Sales 2024 * 480M Sales 2025 * 520M Capitalization 1.62B
Net income 2024 * 165M Net income 2025 * 189M EV / Sales 2024 * 1.36 x
Net cash position 2024 * 968M Net cash position 2025 * 1.19B EV / Sales 2025 * 0.83 x
P/E ratio 2024 *
9.89 x
P/E ratio 2025 *
8.74 x
Employees 581
Yield 2024 *
-
Yield 2025 *
-
Free-Float 90.31%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.32%
1 week+3.46%
Current month-0.05%
1 month+10.90%
3 months-16.62%
6 months-22.09%
Current year-14.03%
More quotes
1 week
18.68
Extreme 18.68
19.71
1 month
17.25
Extreme 17.25
19.71
Current year
16.72
Extreme 16.72
26.80
1 year
16.72
Extreme 16.72
48.25
3 years
16.72
Extreme 16.72
99.27
5 years
6.53
Extreme 6.53
99.27
10 years
6.53
Extreme 6.53
99.27
More quotes
Managers TitleAgeSince
Founder 57 08-01-01
Chief Executive Officer 71 08-01-01
Director of Finance/CFO 46 16-12-31
Members of the board TitleAgeSince
Director/Board Member 89 19-08-06
Chief Executive Officer 71 08-01-01
Founder 57 08-01-01
More insiders
Date Price Change Volume
24-05-31 19.13 +1.38% 799,561
24-05-30 18.87 +0.59% 640,901
24-05-29 18.76 -4.38% 957,269
24-05-28 19.62 +6.17% 1,599,333
24-05-24 18.48 +0.16% 921,840

Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT

More quotes
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
19.13 USD
Average target price
25.6 USD
Spread / Average Target
+33.82%
Consensus